Drugs / ND-340
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04515953 | Oct 2020 → Dec 2025 | neuropathy, painful | Nang Kuang Pharmaceutical Co., Ltd. | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ND-340 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04515953 ↗ |